Shanghai Kai Kai Industry Co Ltd B Total Liabilities
Shanghai Kai Kai Industry Co Ltd B total liabilities. Based on the latest financial reports, Shanghai Kai Kai Industry Co Ltd B (900943) has total liabilities worth $878.36 Million USD as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 900943 financial resilience to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Shanghai Kai Kai Industry Co Ltd B (2015–2024)
Total liabilities of Shanghai Kai Kai Industry Co Ltd B from 2015 to 2024. This chart illustrates how Shanghai Kai Kai Industry Co Ltd B's total liabilities have evolved over time, based on quarterly financial data. Explore Shanghai Kai Kai Industry Co Ltd B strategic investment ratio to see how much of total assets are deployed in long-term investments.
Shanghai Kai Kai Industry Co Ltd B Competitors by Total Liabilities
The table below lists competitors of Shanghai Kai Kai Industry Co Ltd B ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Hitech Group Australia Ltd
AU:HIT
|
Australia | AU$6.60 Million |
|
Asia Plastic Recycling Holding Ltd
TW:1337
|
Taiwan | NT$2.44 Billion |
|
YM Tech Co. Ltd.
KQ:273640
|
Korea | ₩4.19 Billion |
|
Alternative Investment Trust
AU:AIQ
|
Australia | AU$261.00K |
|
Yooshin Engineering Corporation
KQ:054930
|
Korea | ₩184.07 Billion |
|
Mount Ridley Mines Ltd
AU:MRD
|
Australia | AU$52.21K |
|
Royalty Management Holding Corporation
NASDAQ:RMCO
|
USA | $3.95 Million |
|
Headway
TW:1776
|
Taiwan | NT$551.10 Million |
Liability Composition Analysis (2015–2024)
This chart breaks down Shanghai Kai Kai Industry Co Ltd B's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see how large is Shanghai Kai Kai Industry Co Ltd B's balance sheet.
Liquidity & Leverage Metrics
Shanghai Kai Kai Industry Co Ltd B Total Liabilities Ratios Explained
Shanghai Kai Kai Industry Co Ltd B total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.37 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.42 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.57 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Shanghai Kai Kai Industry Co Ltd B's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Shanghai Kai Kai Industry Co Ltd B (2015–2024)
The table below shows the annual total liabilities of Shanghai Kai Kai Industry Co Ltd B from 2015 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $835.87 Million | +16.17% |
| 2023-12-31 | $719.52 Million | +14.39% |
| 2022-12-31 | $629.00 Million | +21.80% |
| 2021-12-31 | $516.43 Million | -1.19% |
| 2020-12-31 | $522.67 Million | +0.42% |
| 2019-12-31 | $520.47 Million | +0.82% |
| 2018-12-31 | $516.24 Million | -4.35% |
| 2017-12-31 | $539.69 Million | +1.61% |
| 2016-12-31 | $531.13 Million | +3.45% |
| 2015-12-31 | $513.44 Million | -- |
About Shanghai Kai Kai Industry Co Ltd B
Shanghai Kai Kai Industry Company Limited engages in the wholesale and retail of pharmaceutical products in China. The company engages in the wholesale and retail of traditional Chinese and Western medicines; medical devices; reagents; consumables and diagnosis; and treatment services, etc. under the Shang Lei brand, as well as production and sale of Chinese patent medicine under the Jing and Que… Read more